Evidence for monoaminergic involvement in triadimefon-induced hyperactivity
- 1 March 1989
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 97 (3) , 326-330
- https://doi.org/10.1007/bf00439445
Abstract
Triadimefon is a triazole fungicide that produces hyperactivity in both mice and rats similar to that seen following administration of compounds with catecholaminergic activity (e.g., d-amphetamine). To determine whether the triadimefon-induced hyperactivity is due to an action on CNS catecholaminergic systems, we evaluated the effects of combined treatment of triadimefon with either the tyrosine hydroxlase inhibitor d,l-α-methyl-p-tyrosine methyl ester HCl (αMPT) or the amine depletor reserpine. Adult male Long-Evans hooded rats, approximately 70 days of age were used. Dosage-effect functions were determined for αMPT (0–200 mg/kg IP), reserpine (0–2.5 mg/kg IP), d-amphetamine (0–3 mg/kg IP), and methylphenidate (0–40 mg/kg IP). Motor activity was measured as photocell interruptions in figure-eight mazes. The interaction between triadimefon and αMPT was determined with the following groups: 1) vehicle control; 2) 200 mg/kg triadimefon PO; 3) 100 mg/kg αMPT; and 4) both αMPT and triadimefon. A similar design was used to determine the interaction between triadimefon and reserpine (0.62 mg/kg), αMPT and d-amphetamine (1.5 mg/kg), and reserpine and methylphenidate (5.0 mg/kg). In the first experiment αMPT did not block the increased motor activity produced by triadimefon (i.e., both triadimefon alone and αMPT in combination with triadimefon produced significant increases in motor activity). αMPT did, however, block d-amphetamine-induced hyperactivity. Since αMPT did not antagonize the effect of triadimefon, these data suggest that increased motor activity produced by triadimefon is not mediated through release of newly synthesized catecholamines. In contrast, pretreatment with reserpine blocked the hyperactivity induced by both triadimefon and methylphenidate, which suggests that triadimefon-induced hyperactivity may be due to an interaction with CNS catecholamines stored in reserpine-sensitive pools.This publication has 35 references indexed in Scilit:
- Hyperactivity induced by triadimefon, a triazole fungicide*1Fundamental and Applied Toxicology, 1988
- Differential effects of amphetamine and related compounds on locomotor activity and metabolic rate in micePharmacology Biochemistry and Behavior, 1986
- Percutaneous absorption of triadimefon in the adult and young male and female ratToxicology and Applied Pharmacology, 1984
- Antagonism of methylphenidate-induced behavior by neostigmine or hemicholinium-3Neuropharmacology, 1981
- Inhibition of ergosterol biosynthesis by triadimenol inUstilago avenaePesticide Science, 1978
- Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in ratsJournal of Pharmacy and Pharmacology, 1977
- Developmental and behavioral changes in the rat during chronic exposure to lead.Environmental Health Perspectives, 1975
- The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugsNeuropharmacology, 1973
- Behavioural Stereotypies Induced by Pharmacological AgentsPharmacopsychiatry, 1968
- Time Correlation Between the Effects of Reserpine on Behaviour and Storage Mechanism for ArylalkylaminesActa Physiologica Scandinavica, 1963